Concepts (142)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tumor Necrosis Factor-alpha | 4 | 2019 | 384 | 1.460 |
Why?
|
| Apigenin | 2 | 2019 | 14 | 1.140 |
Why?
|
| Chemokine CCL2 | 3 | 2019 | 95 | 1.020 |
Why?
|
| Neoplasm Proteins | 2 | 2019 | 228 | 0.670 |
Why?
|
| Breast Neoplasms | 3 | 2019 | 1723 | 0.560 |
Why?
|
| Anti-Inflammatory Agents | 2 | 2017 | 187 | 0.560 |
Why?
|
| Interleukin-1alpha | 1 | 2017 | 18 | 0.520 |
Why?
|
| I-kappa B Kinase | 1 | 2017 | 51 | 0.500 |
Why?
|
| Gene Expression Profiling | 2 | 2019 | 704 | 0.480 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2019 | 968 | 0.450 |
Why?
|
| Microglia | 4 | 2018 | 208 | 0.450 |
Why?
|
| Allyl Compounds | 1 | 2014 | 55 | 0.410 |
Why?
|
| Disulfides | 1 | 2014 | 95 | 0.400 |
Why?
|
| Antineoplastic Agents | 3 | 2016 | 1019 | 0.340 |
Why?
|
| Cytokines | 3 | 2017 | 678 | 0.270 |
Why?
|
| Hydrolyzable Tannins | 2 | 2018 | 20 | 0.270 |
Why?
|
| Cell Line, Tumor | 7 | 2020 | 2676 | 0.270 |
Why?
|
| Interferon-gamma | 5 | 2020 | 269 | 0.260 |
Why?
|
| Lipopolysaccharides | 5 | 2018 | 239 | 0.240 |
Why?
|
| Biological Products | 2 | 2016 | 91 | 0.220 |
Why?
|
| Cell Survival | 5 | 2017 | 945 | 0.200 |
Why?
|
| Cell Proliferation | 3 | 2019 | 1455 | 0.180 |
Why?
|
| Salmonella Infections, Animal | 1 | 2020 | 2 | 0.170 |
Why?
|
| DNA Polymerase II | 1 | 2020 | 5 | 0.160 |
Why?
|
| Salmonella typhimurium | 1 | 2020 | 40 | 0.160 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2020 | 47 | 0.160 |
Why?
|
| DNA Mismatch Repair | 1 | 2020 | 28 | 0.160 |
Why?
|
| Chalcones | 1 | 2019 | 17 | 0.150 |
Why?
|
| High-Throughput Screening Assays | 2 | 2016 | 74 | 0.150 |
Why?
|
| Host-Pathogen Interactions | 1 | 2020 | 209 | 0.140 |
Why?
|
| Protein Array Analysis | 2 | 2017 | 27 | 0.140 |
Why?
|
| Petroselinum | 1 | 2017 | 4 | 0.130 |
Why?
|
| Inflammation Mediators | 1 | 2018 | 140 | 0.130 |
Why?
|
| Liver | 1 | 2020 | 511 | 0.130 |
Why?
|
| Chemokine CXCL2 | 1 | 2016 | 12 | 0.130 |
Why?
|
| Nitrogen Dioxide | 1 | 2016 | 17 | 0.130 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2017 | 64 | 0.130 |
Why?
|
| MAP Kinase Signaling System | 1 | 2018 | 196 | 0.120 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2017 | 458 | 0.120 |
Why?
|
| Benzoquinones | 1 | 2016 | 47 | 0.120 |
Why?
|
| Humans | 12 | 2024 | 43102 | 0.120 |
Why?
|
| Female | 7 | 2019 | 24698 | 0.120 |
Why?
|
| Gene Silencing | 1 | 2017 | 154 | 0.120 |
Why?
|
| Lactic Acid | 1 | 2017 | 112 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-met | 1 | 2016 | 9 | 0.120 |
Why?
|
| Breast | 1 | 2017 | 139 | 0.120 |
Why?
|
| Sepsis | 1 | 2016 | 90 | 0.120 |
Why?
|
| Glioma | 1 | 2016 | 96 | 0.120 |
Why?
|
| NF-kappa B | 1 | 2018 | 358 | 0.120 |
Why?
|
| Pyridones | 1 | 2016 | 50 | 0.120 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2017 | 134 | 0.110 |
Why?
|
| Triazoles | 1 | 2016 | 102 | 0.110 |
Why?
|
| Nucleotides, Cyclic | 1 | 2014 | 6 | 0.110 |
Why?
|
| Mice | 8 | 2020 | 6644 | 0.110 |
Why?
|
| Enterotoxigenic Escherichia coli | 1 | 2014 | 5 | 0.110 |
Why?
|
| RNA, Small Interfering | 1 | 2017 | 436 | 0.110 |
Why?
|
| Enterotoxins | 1 | 2014 | 33 | 0.110 |
Why?
|
| Bacterial Toxins | 1 | 2014 | 50 | 0.110 |
Why?
|
| Adipokines | 1 | 2014 | 28 | 0.110 |
Why?
|
| Garlic | 1 | 2014 | 31 | 0.110 |
Why?
|
| Escherichia coli | 1 | 2016 | 460 | 0.100 |
Why?
|
| Tumor Cells, Cultured | 1 | 2014 | 508 | 0.100 |
Why?
|
| Escherichia coli Proteins | 1 | 2014 | 133 | 0.100 |
Why?
|
| Anti-Bacterial Agents | 1 | 2016 | 432 | 0.100 |
Why?
|
| Antioxidants | 1 | 2016 | 443 | 0.100 |
Why?
|
| Macrophages | 1 | 2016 | 529 | 0.090 |
Why?
|
| Water | 1 | 2014 | 316 | 0.090 |
Why?
|
| Epithelial Cells | 1 | 2014 | 434 | 0.090 |
Why?
|
| Animals | 9 | 2020 | 16992 | 0.080 |
Why?
|
| Cell Line | 3 | 2018 | 1410 | 0.070 |
Why?
|
| Interferon-beta | 1 | 2008 | 9 | 0.070 |
Why?
|
| Immunologic Factors | 1 | 2008 | 51 | 0.070 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2008 | 33 | 0.070 |
Why?
|
| Naphthalenes | 1 | 2008 | 38 | 0.070 |
Why?
|
| Signal Transduction | 1 | 2017 | 2157 | 0.070 |
Why?
|
| Adjuvants, Immunologic | 1 | 2008 | 117 | 0.070 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2017 | 1124 | 0.060 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2008 | 159 | 0.060 |
Why?
|
| Apoptosis | 1 | 2014 | 1568 | 0.060 |
Why?
|
| Gene Expression | 1 | 2008 | 701 | 0.060 |
Why?
|
| Endothelial Cells | 1 | 2008 | 329 | 0.050 |
Why?
|
| Nitric Oxide | 2 | 2017 | 386 | 0.050 |
Why?
|
| Drug Evaluation, Preclinical | 2 | 2016 | 127 | 0.050 |
Why?
|
| Crystallography, X-Ray | 2 | 2016 | 280 | 0.040 |
Why?
|
| Vaccination | 1 | 2024 | 355 | 0.040 |
Why?
|
| Drug Design | 2 | 2016 | 186 | 0.040 |
Why?
|
| Structure-Activity Relationship | 2 | 2016 | 506 | 0.040 |
Why?
|
| GATA3 Transcription Factor | 1 | 2020 | 4 | 0.040 |
Why?
|
| Gallbladder | 1 | 2020 | 5 | 0.040 |
Why?
|
| Coculture Techniques | 1 | 2020 | 109 | 0.040 |
Why?
|
| Lymph Nodes | 1 | 2020 | 74 | 0.040 |
Why?
|
| Organ Specificity | 1 | 2020 | 141 | 0.040 |
Why?
|
| Mutagenesis | 1 | 2020 | 91 | 0.040 |
Why?
|
| Macrophage Activation | 1 | 2020 | 61 | 0.040 |
Why?
|
| Interleukin-10 | 1 | 2020 | 87 | 0.040 |
Why?
|
| Mice, Inbred BALB C | 2 | 2014 | 694 | 0.040 |
Why?
|
| Spleen | 1 | 2020 | 204 | 0.040 |
Why?
|
| Prospective Studies | 1 | 2024 | 1600 | 0.040 |
Why?
|
| Immunity, Innate | 1 | 2020 | 171 | 0.040 |
Why?
|
| Alleles | 1 | 2020 | 352 | 0.040 |
Why?
|
| Models, Molecular | 2 | 2016 | 876 | 0.040 |
Why?
|
| Chronic Disease | 1 | 2020 | 549 | 0.030 |
Why?
|
| Cell Line, Transformed | 1 | 2017 | 95 | 0.030 |
Why?
|
| Lipid Peroxides | 1 | 2016 | 19 | 0.030 |
Why?
|
| Glycolysis | 1 | 2017 | 71 | 0.030 |
Why?
|
| Isoenzymes | 1 | 2017 | 168 | 0.030 |
Why?
|
| Superoxides | 1 | 2016 | 57 | 0.030 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2017 | 95 | 0.030 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2017 | 128 | 0.030 |
Why?
|
| Catalase | 1 | 2016 | 110 | 0.030 |
Why?
|
| Adenosine Triphosphate | 1 | 2017 | 206 | 0.030 |
Why?
|
| Superoxide Dismutase | 1 | 2016 | 158 | 0.030 |
Why?
|
| Neutrophils | 1 | 2016 | 145 | 0.030 |
Why?
|
| Glutathione | 1 | 2016 | 171 | 0.030 |
Why?
|
| Hydrogen Peroxide | 1 | 2016 | 190 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 1 | 2017 | 455 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 2017 | 575 | 0.030 |
Why?
|
| Glucose | 1 | 2017 | 244 | 0.030 |
Why?
|
| Rats | 2 | 2016 | 3735 | 0.030 |
Why?
|
| Mutation | 1 | 2020 | 1177 | 0.030 |
Why?
|
| Gene Expression Regulation | 1 | 2020 | 1070 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2017 | 456 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 1 | 2020 | 1869 | 0.030 |
Why?
|
| Drug Discovery | 1 | 2016 | 108 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2016 | 347 | 0.030 |
Why?
|
| Adult | 2 | 2024 | 13872 | 0.020 |
Why?
|
| Neoplasms | 1 | 2020 | 1377 | 0.020 |
Why?
|
| Corneal Neovascularization | 1 | 2008 | 6 | 0.020 |
Why?
|
| Injections, Intravenous | 1 | 2008 | 67 | 0.020 |
Why?
|
| Principal Component Analysis | 1 | 2008 | 87 | 0.020 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2008 | 99 | 0.020 |
Why?
|
| Stereoisomerism | 1 | 2008 | 169 | 0.020 |
Why?
|
| Microsomes, Liver | 1 | 2008 | 75 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2008 | 317 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2008 | 310 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2008 | 260 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2008 | 408 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2008 | 652 | 0.020 |
Why?
|
| Molecular Structure | 1 | 2008 | 570 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2008 | 1081 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2008 | 1766 | 0.010 |
Why?
|
| Male | 2 | 2008 | 23409 | 0.010 |
Why?
|